LifeStance Health GroupLFST -1.49%56 12-1 Month Momentum % is 62.51% as of Jul. 03, 2026. GuruFocus rates LFST with a GF Score™ of 56/100 and a GF Value™ of $8.25 (Significantly Overvalued). The stock has 5 warning signs investors should review. Among 662 Healthcare Providers & Services companies, LifeStance Health Group ranks better than 90.18% on this metric.
12-1 Month Momentum % is the total return of the stock from 12-month ago to 1-month ago. As of today (2026-07-03), LifeStance Health Group's 12-1 Month Momentum % is 62.51%.
The industry rank for LifeStance Health Group's 12-1 Month Momentum % or its related term are showing as below:
LFST's 12-1 Month Momentum % is ranked better than 90.18% of 662
companies
in the Healthcare Providers & Services industry
Industry Median: -10.145
vs LFST: 62.51
LifeStance Health Group (NAS:LFST) 12-1 Month Momentum % Explanation
Momentum investing is a trading strategy in which investors buy securities that are rising and sell before the prices start to go back down. The 12-1 Month Momentum % measures the total return to a stock over the past twelve months, but ignores the previous month.
The reason why the most recent month’s return dropped related to the short-term reversal effect associated with momentum. There is an academic finding that short-term momentum actually has a reversal effect, whereby the previous winners (measured over the past months) do poorly the next month, while the previous losers do well the next month. In order to eliminate the short-term reversal effect, the previous month return was not included in this calculation.
LifeStance Health Group 12-1 Month Momentum % Related Terms
LFST vs CON, BKD, OPCH: 12-1 Month Momentum % Comparison
For the Medical Care Facilities subindustry, LifeStance Health Group's 12-1 Month Momentum %, along with its competitors' market caps and 12-1 Month Momentum % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
LifeStance Health Group 12-1 Month Momentum % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, LifeStance Health Group's 12-1 Month Momentum % distribution charts can be found below:
* The bar in red indicates where LifeStance Health Group's 12-1 Month Momentum % falls into.
LifeStance Health Group (NAS:LFST) 12-1 Month Momentum % Calculation
12-1 Month Momentum % is calculated as following:
12-1 Month Momentum %
=
( Price 1-month ago
/
Price 12-month ago
- 1 )
*
100 %
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
LifeStance Health Group (LFST) has a 12-1 Month Momentum % of 62.51% as of Jul. 03, 2026. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on LifeStance Health Group and its competitors. According to the industry distribution chart, LifeStance Health Group ranks #65 out of 662 companies in the Healthcare Providers & Services industry, placing it in the top 9.8%.
Is LifeStance Health Group's 12-1 Month Momentum % too high?
LifeStance Health Group's current 12-1 Month Momentum % is 62.51%. Based on the distribution chart, LifeStance Health Group ranks #65 out of 662 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, LifeStance Health Group has a GF Score™ of 56/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does LifeStance Health Group's 12-1 Month Momentum % compare to CON and BKD?
According to the Healthcare Providers & Services industry distribution chart, LifeStance Health Group ranks #65 out of 662 companies for 12-1 Month Momentum %. This places LifeStance Health Group in the top 10% of its industry — outperforming the majority of peers. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good 12-1 Month Momentum % for a Healthcare Providers & Services company?
A good 12-1 Month Momentum % depends on the Healthcare Providers & Services industry context. However, 12-1 Month Momentum % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high 12-1 Month Momentum % mean?
A high 12-1 Month Momentum % can signal that a stock is expensive relative to its fundamentals. 12-1 Month Momentum measures the total return of the stock from 12-month ago to 1-month ago. View historical data on LifeStance Health Group and its competitors. LifeStance Health Group's current 12-1 Month Momentum % is 62.51%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is LifeStance Health Group stock overvalued right now?
Based on GuruFocus' analysis, LifeStance Health Group (LFST) is currently considered Significantly Overvalued. The stock's GF Value™ is $8.25, compared to a current price of $11.27 — trading 36.6% above its estimated fair value. The current 12-1 Month Momentum % is 62.51%. LifeStance Health Group's overall GF Score™ is 56/100 with 5 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is 12-1 Month Momentum % calculated?
12-1 Month Momentum % is calculated from a company's financial statements. For LifeStance Health Group (LFST), the current 12-1 Month Momentum % is 62.51% as of Jul. 03, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is LifeStance Health Group (LFST) Overvalued in 2026?
Based on GuruFocus' analysis, LifeStance Health Group stock appears to be overvalued.
The current stock price of $11.27 is trading 36.6% above its estimated GF Value™ of $8.25.
GuruFocus considers LifeStance Health Group to be Significantly Overvalued.
Key valuation signals for LFST:
12-1 Month Momentum %: 62.51%
GF Value™: $8.25 vs. price of $11.27 (36.6% above fair value)
No single metric tells the full story. See the LFST stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
LifeStance Health Group Inc is a mental healthcare company that operates as a provider of outpatient mental health services, spanning psychiatric evaluations and treatment, psychological and neuropsychological testing, and individual, family, and group therapy. It treats a broad range of mental health conditions, including anxiety, depression, bipolar disorder, eating disorders, psychotic disorders, and post-traumatic stress disorder, using evidence-based approaches to ensure effective treatment. The group has a single operating and reportable segment of mental health services.
56GF Score
Get the complete analysis for LFST
12-1 Month Momentum % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LFST has been successfully added to your 